Marius Pharmaceuticals Strengthens IP Portfolio with New KYZATREX® (testosterone undecanoate) CIII Capsules Formulation Patent
This marks Marius Pharmaceuticals’ fifth U.S. patent, further reinforcing its leadership in the field of testosterone replacement therapy. The newly allowed patent specifically covers the company’s ...
Global Softgel Capsules Market Projected to Grow at a CAGR of 7.7%
According to the latest study from BCC Research, "Softgel Capsules: Global Markets" is expected to grow from $7.9 billion in 2024 to $11.5 billion by the end of 2029, at a compound annual growth rate ...
Here's why Marksans Pharma share was buzzing in trade on March 20
The products will be manufactured at the Verna, Goa facility, and will be marketed & distributed in Australian markets ...
The Pharma Letter7d
Phase IIa success for EnteroBiotix microbiome product
Scottish gut health specialist EnteroBiotix has announced positive initial results with EBX-102-02, its full-spectrum microbiome product, from the TrIuMPH Phase IIa trial in adults with irritable ...
MarketersMEDIA Newsroom5d
Fleava Unveils Advanced Hair Care Solutions, Outpacing Traditional Big Pharma Treatments
Fleava offers natural, science-backed hair care solutions without the risks and side effects associated with big pharma ...
Marksans Pharma rises after receiving regulatory nod for supplying pharma products to Australia
Marksans Pharma added 2.22% to Rs 207.35 after the company announced that its Goa-based manufacturing facility has been approved by Australian TGA for manufacture of pharmaceutical formulations for ...